IL140938A0 - Molecules designated b7l-1 - Google Patents

Molecules designated b7l-1

Info

Publication number
IL140938A0
IL140938A0 IL14093899A IL14093899A IL140938A0 IL 140938 A0 IL140938 A0 IL 140938A0 IL 14093899 A IL14093899 A IL 14093899A IL 14093899 A IL14093899 A IL 14093899A IL 140938 A0 IL140938 A0 IL 140938A0
Authority
IL
Israel
Prior art keywords
molecules designated
molecules
designated
polypeptides
purified
Prior art date
Application number
IL14093899A
Other languages
English (en)
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of IL140938A0 publication Critical patent/IL140938A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL14093899A 1998-08-07 1999-08-05 Molecules designated b7l-1 IL140938A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9566398P 1998-08-07 1998-08-07
PCT/US1999/017906 WO2000008057A2 (en) 1998-08-07 1999-08-05 Molecules designated b7l-1

Publications (1)

Publication Number Publication Date
IL140938A0 true IL140938A0 (en) 2002-02-10

Family

ID=22253041

Family Applications (3)

Application Number Title Priority Date Filing Date
IL14093899A IL140938A0 (en) 1998-08-07 1999-08-05 Molecules designated b7l-1
IL140938A IL140938A (en) 1998-08-07 2001-01-17 Dna sequences encoding polypeptides capable of binding to ldcam, polypeptides encoded by them, fusion proteins comprising the polypeptides and a process for the preparation of the polypeptides
IL196509A IL196509A (en) 1998-08-07 2009-01-14 Antibodies directed against polypeptides capable of binding to ldcam and pharmaceutical compositions comprising the same

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL140938A IL140938A (en) 1998-08-07 2001-01-17 Dna sequences encoding polypeptides capable of binding to ldcam, polypeptides encoded by them, fusion proteins comprising the polypeptides and a process for the preparation of the polypeptides
IL196509A IL196509A (en) 1998-08-07 2009-01-14 Antibodies directed against polypeptides capable of binding to ldcam and pharmaceutical compositions comprising the same

Country Status (10)

Country Link
US (3) US6512095B2 (xx)
EP (1) EP1108042B1 (xx)
AT (1) ATE415480T1 (xx)
AU (1) AU771640B2 (xx)
CA (1) CA2337712A1 (xx)
DE (1) DE69939982D1 (xx)
ES (1) ES2315016T3 (xx)
IL (3) IL140938A0 (xx)
NZ (1) NZ510357A (xx)
WO (1) WO2000008057A2 (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144478A1 (en) * 2001-02-06 2003-07-31 Immunex Corporation Molecules designated B7L-1
ES2315016T3 (es) * 1998-08-07 2009-03-16 Immunex Corporation Moleculas llamadas b7l-1.
EP1102848B1 (en) * 1998-08-07 2010-10-13 Immunex Corporation Molecules designated ldcam
WO2000032633A1 (en) * 1998-12-02 2000-06-08 Icos Corporation Novel adhesion molecule and methods of use
EP1514933A1 (en) * 1999-07-08 2005-03-16 Research Association for Biotechnology Secretory protein or membrane protein
US7129338B1 (en) * 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein
EP1222205A4 (en) * 1999-10-18 2004-03-31 Texas Biotechnology Corp POLYNUCLEOTIDES ENCODING HUMAN PROTEINS AND MURINES (BIGR)
US6965018B2 (en) 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
CA2413547A1 (en) * 2000-06-28 2002-01-03 Amgen, Inc. B7-like molecules and uses thereof
EP1414948B1 (en) * 2001-07-10 2009-09-16 Biogen Idec Inc. Inhibition of apoptosis process and improvement of cell performance
JP2003116561A (ja) * 2001-10-11 2003-04-22 National Cancer Center-Japan Ｔｓｌｌ１遺伝子
AU2003238251B2 (en) * 2002-06-17 2009-05-21 Wyeth Inhibition of T cell activation by butyrophilin 4 or B7-L1
WO2005012530A2 (en) * 2003-07-25 2005-02-10 Amgen Inc. Antagonists and agonists of ldcam and methods of use
DE602007009954D1 (de) * 2006-03-22 2010-12-02 Viral Logic Systems Technology Verfahren zur identifizierung von polypeptid-targets
ES2625259T3 (es) * 2006-08-29 2017-07-19 Oxford Biotherapeutics Ltd Identificación de proteína asociada con carcinoma hepatocelular, glioblastoma y cáncer de pulmón
PT2403878T (pt) 2009-03-05 2017-09-01 Squibb & Sons Llc Anticorpos completamente humanos específicos a cadm1
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
WO2014144817A2 (en) 2013-03-15 2014-09-18 Amgen Inc. Inhibitory polypeptides specific to wnt inhibitors
JP6426738B2 (ja) * 2013-07-30 2018-11-21 エイチ．ビー．フラー カンパニー ポリウレタン接着フィルム
AU2014318017B2 (en) 2013-09-05 2020-02-06 Amgen Inc. Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
AU2015259053B2 (en) 2014-05-16 2020-12-24 Amgen Inc. Assay for detecting Th1 and Th2 cell populations
JP2020513813A (ja) 2017-03-14 2020-05-21 アムジエン・インコーポレーテツド 細胞培養において産生される抗体の総非フコシル化グリコフォームの調節
JP2021519068A (ja) 2018-03-26 2021-08-10 アムジェン インコーポレイテッド 細胞培養において産生される抗体の総非フコシル化グリコフォーム
US20220349898A1 (en) 2019-09-26 2022-11-03 Amgen Inc. Methods of producing antibody compositions
US20230273126A1 (en) 2020-06-04 2023-08-31 Amgen Inc. Assessment of cleaning procedures of a biotherapeutic manufacturing process
MX2023004364A (es) 2020-10-15 2023-05-03 Amgen Inc Glucanos no emparejados relativos en metodos de produccion de anticuerpos.
AU2022289365A1 (en) 2021-06-07 2023-12-14 Amgen Inc. Using fucosidase to control afucosylation level of glycosylated proteins
AU2022361382A1 (en) 2021-10-05 2024-03-28 Amgen Inc. Fc-gamma receptor ii binding and glycan content
WO2023215725A1 (en) 2022-05-02 2023-11-09 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218510B1 (en) 1994-03-02 2001-04-17 Brigham & Woman's Hospital B7-1 and B7-2 polypeptides
WO2000053753A2 (en) 1999-03-08 2000-09-14 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
WO1998054963A2 (en) 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins
CA2285447A1 (en) 1997-03-28 1998-10-08 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1998044113A1 (en) * 1997-03-28 1998-10-08 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
ATE447583T1 (de) 1997-09-17 2009-11-15 Genentech Inc Polypeptide und dafür kodierende nukleinsäure
EP0939124A3 (en) 1998-02-24 2001-03-21 Smithkline Beecham Plc MGBP1 sequences
ES2315016T3 (es) 1998-08-07 2009-03-16 Immunex Corporation Moleculas llamadas b7l-1.
WO2000032633A1 (en) 1998-12-02 2000-06-08 Icos Corporation Novel adhesion molecule and methods of use
CN1242376A (zh) 1999-07-27 2000-01-26 中国医学科学院基础医学研究所 人神经系统特异表达基因

Also Published As

Publication number Publication date
CA2337712A1 (en) 2000-02-17
US20080075724A1 (en) 2008-03-27
NZ510357A (en) 2004-02-27
EP1108042A2 (en) 2001-06-20
AU771640B2 (en) 2004-04-01
ES2315016T3 (es) 2009-03-16
US20100168399A1 (en) 2010-07-01
ATE415480T1 (de) 2008-12-15
IL196509A (en) 2011-04-28
WO2000008057A2 (en) 2000-02-17
IL140938A (en) 2010-12-30
US6512095B2 (en) 2003-01-28
DE69939982D1 (de) 2009-01-08
US20020164686A1 (en) 2002-11-07
US7939640B2 (en) 2011-05-10
AU5550499A (en) 2000-02-28
IL196509A0 (en) 2009-09-22
WO2000008057A3 (en) 2000-05-18
EP1108042B1 (en) 2008-11-26

Similar Documents

Publication Publication Date Title
NZ510357A (en) Molecules designated B7L-1
IL140937A0 (en) Molecules designated ldcam
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
IL193919A0 (en) DcR3 POLYPEPTIDE A TNFR HOMOLOG
HK1040401A1 (en) Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof
HK1013847A1 (en) Gdf-1 and uog-1 proteins
EP0712862A3 (en) Selective acylation of epsilon-amino groups
IL137037A0 (en) Acpl dna and polypeptides
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
AU3802595A (en) Tripeptidyl aminopeptidase
MX9702341A (es) Citoquina designada lerk-6.
NZ294019A (en) Proteins associated with the hippocampus; dna sequences coding therefor, antibodies to the proteins
DE69939587D1 (en) Semaphorin polypeptide
AU3118095A (en) Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme
WO2000044898A3 (en) Novel agouti and agouti-related peptide analogs
AU4046599A (en) Plant protein with repeated wd40 motifs, nucleic acid coding for said protein, and uses thereof
ZA99445B (en) Isolated, polypeptides which bind to HLA-A29 molecules nucleic acid, the molecules encoding these, and uses thereof.
SG74579A1 (en) Enzyme with leudh activity, nucleotide sequence coding therefor and process for the preparation of the enzyme
TW342413B (en) Novel toxins isolated from Bracon Hebetor
IE882662L (en) Dna sequences, recombinant dna molecules for producing¹soluble t4 proteins